SCHEMBL7575664

SCHEMBL7575664

COc1ccc(NC(C(=O)O)c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
KDM4E B2RXH2 1/20 0.61
MAPT P10636 1/20 0.61
ATM Q13315 1/20 0.57
TDP1 Q9NUW8 1/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
KLK7 P49862 4/20 0.51
CASR P41180 1/20 0.51
HTT P42858 2/20 0.49
NPY5R Q15761 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CRHBP P24387 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9298424 0.94 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTATMTDP1
SCHEMBL2485730 0.94 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTATMTDP1
Hydrochloric Acid SCHEMBL2483358 0.92 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTATMTDP1
SCHEMBL28529501 0.89 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTATMTDP1
SCHEMBL28987193 0.86 ALDH1A1 (0.64) ALDH1A1KDM4EMAPTTDP1MEN1
SCHEMBL22215228 0.86 ALDH1A1 (0.64) ALDH1A1KDM4EMAPTTDP1MEN1
SCHEMBL5954418 0.85 MMP2 (0.55) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL5954420 0.85 MMP2 (0.55) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL29927511 0.84 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTATMTDP1
SCHEMBL13282701 0.83 POLB (0.67) ALDH1A1KDM4EMAPTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed